The Investment Opportunity of AllerPops

Anyone who suffers from allergies can tell you they would likely try anything to manage their symptoms. However, allergy sufferers may be unaware of one of the main reasons behind their life-disrupting allergy attacks — a lack of good bacteria. 

Next to the gut, your mouth and airway host the most probiotics, which are good bacteria that provide a number of health benefits. A lack of good bacteria can be the culprit behind allergy attacks and replenishing probiotics can help sufferers find relief.

Allergies are nothing more than our body’s reaction to a substance. The physiological responses of allergies can range from mild itching or watery eyes to life-threatening anaphylactic shock. 

Our product, AllerPops, are clinically proven to be effective for long-lasting allergy relief. We have applied what has been learned about probiotics and allergies and given sufferers a way to replenish the good bacteria in their mouths and airways, leading to a suppression of the worst allergy symptoms and often complete remission.

Backed by research

Scientific studies over the past 28 years have aided in the creation of AllerPops. After studying a number of allergy sufferers, scientists have found — through longitudinal, cross-sectional, and translational studies — that a lack of beneficial bacteria, Streptococcus and Veilonella, in the subject’s oral/nasal cavities contributed to the emergence of allergy symptoms. We developed a prebiotic mix containing an expertly formulated formula with DNA sequence-verified probiotic support and put them into an easily digestible “lollipop”. 

Allergies can significantly alter someone’s life, especially if they are severe. Common allergies, such as hay fever or seasonal allergies, are not life-threatening, but they can range from being an annoyance to contributing to limiting certain activities. Typical symptom relief can make people drowsy and give them “medicine head,” making them unable to properly function at work or at home.

The scientific research and discovery behind the benefits of probiotics for allergies have allowed us to bring probiotic treatment to the allergy-sufferer community. The probiotics act as a bridge between the good bacteria and the sufferer’s immune system, calming the worst of their symptoms and, as mentioned, sometimes leading to symptoms disappearing altogether. 

AllerPops work in tandem with a healthy diet and proper oral hygiene to create an environment where good bacteria can flourish and go to work combating the negative effects of bad bacteria and allergens. 

Investing in AllerPops

During the product development and market testing phase, AllerPops generated an impressive revenue of $230,000. The satisfaction rate among customers has reached 94.5%, with over 10,000 customers singing the praises of what AllerPops has done to quell their allergy issues. 

With over 100 million allergy sufferers in America alone, AllerPops is uniquely positioned to capitalize on a market in dire need of relief. There is a ready-made market of millions that have tried the standard allergy medicines, but are now ready to attempt a new approach. 

We have filed five international patent applications for AllerPops. We also currently hold six USPTO-issued patents and one from Australia. We endeavor to continually enhance our product and service in order to meet the demands of an anticipated rapid market expansion over the next 5 to 10 years. Those interested in investing in this disruptive allergy treatment can check out the company at WeFunder. 

AllerPops are the all-natural option people have been waiting for, following years of sleep-inducing pills and uncomfortable nose sprays that can create long-term issues after regular use. Years of dedicated research have allowed us to bring a product to the market that doesn’t just mask symptoms, but gets to the root of why symptoms exist in the first place. The global allergy market stands at $40 billion, and the introduction of the science behind probiotic links to allergy relief is well-positioned to change the trajectory of this market and help millions find a solution to their allergy issues.